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Abstract
Objective: Temporal lobe epilepsy (TLE) patients exhibit signs of memory
impairments even when seizures are pharmacologically controlled. Surprisingly,
the underlying molecular mechanisms involved in TLE-associated memory
impairments remain elusive. Memory consolidation requires epigenetic tran-
scriptional regulation of genes in the hippocampus; therefore, we aimed to
determine how epigenetic DNA methylation mechanisms affect learning-
induced transcription of memory-permissive genes in the epileptic hippocam-
pus. Methods: Using the kainate rodent model of TLE and focusing on the
brain-derived neurotrophic factor (Bdnf) gene as a candidate of DNA methyla-
tion-mediated transcription, we analyzed DNA methylation levels in epileptic
rats following learning. After detection of aberrant DNA methylation at the
Bdnf gene, we investigated functional effects of altered DNA methylation on
hippocampus-dependent memory formation in our TLE rodent model. Results:
We found that behaviorally driven Bdnf DNA methylation was associated with
hippocampus-dependent memory deficits. Bisulfite sequencing revealed that
decreased Bdnf DNA methylation levels strongly correlated with abnormally
high levels of Bdnf mRNA in the epileptic hippocampus during memory con-
solidation. Methyl supplementation via methionine (Met) increased Bdnf DNA
methylation and reduced Bdnf mRNA levels in the epileptic hippocampus
during memory consolidation. Met administration reduced interictal spike
activity, increased theta rhythm power, and reversed memory deficits in epilep-
tic animals. The rescue effect of Met treatment on learning-induced Bdnf DNA
methylation, Bdnf gene expression, and hippocampus-dependent memory, were
attenuated by DNA methyltransferase blockade. Interpretation: Our findings
suggest that manipulation of DNA methylation in the epileptic hippocampus
should be considered as a viable treatment option to ameliorate memory
impairments associated with TLE.
Introduction
Temporal lobe epilepsy (TLE) is a partial adult onset
form of human epilepsy that is commonly associated with
memory deficits.1 However, the underlying molecular
mechanisms responsible for memory loss with TLE are
unclear. DNA methylation, typically associated with gene
silencing, is a potent epigenetic regulator of gene tran-
scription involved in central nervous system development,
synaptic plasticity, and long-term memory formation.2–5
DNA methylation is catalyzed by DNA methyltransferases
(DNMT)6 and has been shown to be involved in TLE.7–11
Furthermore, interference with DNMT-mediated global
and loci-specific DNA methylation changes increased field
excitatory postsynaptic potentials in the epileptic hippo-
campus and lowered seizure threshold in a rodent TLE
model,10 indicating that DNA methylation may play an
important role in seizure susceptibility and possibly the
maintenance of the disorder. It is tempting to speculate,
therefore, that global and gene-specific elevations in DNA
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methylation with TLE may serve as a compensatory
mechanism to control seizure activity by decreasing
proepileptic neuronal gene expression.10
Alterations in memory-permissive genes, such as brain-
derived neurotrophic factor (Bdnf), correlate with TLE and
may contribute to the development, maintenance, and
severity of the disorder.12–14 Chronic overexpression or
downregulation in Bdnf expression has been linked to
memory impairments.15,16 Additionally, activity-dependent
Bdnf gene transcription in the hippocampus is controlled
by DNA methylation mechanisms during memory forma-
tion3,17,18 and Bdnf DNA methylation is abnormally
regulated in the epileptic hippocampus.10,17 Therefore, we
hypothesize that a consequence of TLE-associated DNA
methylation changes is that normal transcription of neuro-
nal genes required for proper memory formation, such as
Bdnf, are severely compromised in the epileptic hippocam-
pus and contribute to epilepsy-associated memory deficits.
Using a rodent hippocampus-dependent memory para-
digm, we found that Bdnf DNA methylation levels signifi-
cantly decreased while Bdnf mRNA levels increased in the
epileptic hippocampus during memory consolidation.
Methyl supplementation with Met significantly increased
Bdnf DNA methylation levels, restored Bdnf mRNA levels in
the epileptic hippocampus, reversed hippocampus-depen-
dent memory deficits, and in electroencephalography (EEG)
studies, decreased interictal spike activity while increasing
theta rhythm power. Inhibition of DNMT activity blocked
the effect of methyl supplementation with Met on Bdnf DNA
methylation and mRNA levels in the epileptic hippocampus,
and prevented the effects on memory enhancements. Collec-
tively, these results suggest that aberrant DNA methylation-
mediated gene transcription contributes to TLE-associated
memory deficits, and that methyl supplementation via Met
may be an effective therapeutic option for reversing hippo-
campus-dependent memory impairments.
Materials and Methods
Animals
Adult male Sprague Dawley rats (250–300 g) were used for
all experiments. Animals were double housed in a 12 h
light/dark cycle and allowed access to food and water ad
libitum. Procedures were performed with the approval of
the University of Alabama at Birmingham Institutional
Animal Care and Use Committee and according to the
national policies and guidelines.
Kainate treatment
Animals were injected with kainic acid (KA) (10 mg/kg;
Tocris Cookson Inc., Ellisville, MO) or saline (vehicle)
intraperitoneally (i.p.). Behavioral seizures following KA
injection were scored following the Racine scale.19 Ani-
mals were considered in status epilepticus (SE) when they
reached a score of 4 or 5 on the Racine scale. Vehicle-
treated animals were handled in the same manner as the
kainate-treated animals, except for KA administration. All
animals were sacrificed 3 weeks post-SE and all kainate-
treated animals used in the study had observable seizures.
The hippocampus was removed and placed in ice-cold
oxygenated (95%/5% O2/CO2) cutting solution
(110 mmol/L sucrose, 60 mmol/L NaCl, 3 mmol/L KCl,
1.25 mmol/L NaH2PO4, 28 mmol/L NaHCO3, 0.5 mmol/
L CaCl2, 7 mmol/L MgCl2, 5 mmol/L glucose, 0.6 mmol/
L ascorbate). Area CA1 was microdissected and frozen
immediately on dry ice. The tissue was stored at 80°C.
Drug treatments
Animals were i.p. injected with saline (0.9% NaCl, pH
7.4), methionine (100 mg/kg; Sigma-Aldrich, St. Louis,
Missouri, USA), or 5-aza-20-deoxycytidine (0.4 mg/kg;
Sigma-Aldrich) 1 h before behavioral testing, 1.5 h before
sacrifice for amino acid array experiments, or 3 h before
sacrificing for all other molecular experiments. These time
points were selected because optimal bdnf expression lev-
els are reached at 2 h post fear training.3 Importantly,
prior to behavioral studies, we confirmed that methionine
administration resulted in increased methionine levels in
the hippocampus at 1.5 h postmethionine treatment as
described previously,20 which precede its effect on DNA
methylation and subsequent gene expression. Thus,
methionine was administered 1 h prior to behavioral
training and animals were sacrificed at 2 h posttraining.
As controls for these experiments, homecaged/untrained
animals (controls) were sacrificed at 3 h postmethionine
administration.
Real time PCR
RNA was extracted from hippocampal area CA1 (AllPrep
DNA/RNA Mini Kit, Qiagen, Hilden, Germany), then
0.3 lg of RNA was converted to cDNA (iSript RT-PCR
iQ SYBR Green Supermix, Bio-Rad, Hercules, CA). Q-
PCR amplifications were performed on the iQ5 real time
PCR system (Bio-Rad) at 95.0°C for 3 min, 40 repeats of
95.0°C for 15 sec, followed by 58.0°C for 1 min, 95.0°C
for 1 min, 55.0°C for 1 min, 81 repeats of 55.0°C for
10 sec each, and, finally, held at 4.0°C, using primer sets
to amplify cDNA designed for Bdnf IX (sense 50–GAGA-
AGAGTGATGACCATCCT–30; antisense 50–TCACGTGCT
CAAAAGTGTCAG–30) and Gapdh (sense 50–ACCTTTG
ATGCTGGGGCTGGC–30; antisense 50–GGGCTGAGTTG
GGATGGGGACT–30). All samples were run in duplicate
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at a primer molarity of 10 lmol/L and Bdnf was com-
pared to Gapdh. Expression of Gapdh was unchanged
across all treatment groups. Cycle threshold (Ct) values
were analyzed using the comparative Ct method to calcu-
late differences in gene expression between samples.
Direct bisulfite DNA sequencing
DNA was extracted from hippocampal area CA1 (AllPrep
DNA/RNA Mini Kit, Qiagen), with 1 lg of DNA used for
bisulfite modification (EpiTect Bisulfite Kit, Qiagen).
Bisulfite-treated DNA was then amplified for a primer
targeting 12 CpG sites within promoter 4 and exon IV
of the Bdnf gene for sequencing with the sense strand as
(50–GGTAGAGGAGGTATTATATGATAGTTTA–30); and
the antisense strand as (50–TACTCCTATTCTTCAACAAA
AAAATTAAAT–30). The thermocycler protocol used to
amplify bisulfite-modified DNA was as follows: 5 min at
95°C, 50 repeats at 95°C for 1 min, followed by 60°C for
1 min, followed by 72°C for 1 min, which was then fol-
lowed by a final cycle of 5 min at 72°C and then termi-
nated at 4°C. The PCR products were cleaned (ExoSAP-
IT (Affymetrix, Santa Clara, CA) and sequenced using the
Bdnf reverse primer (UAB Heflin Center for Human
Genetics, http://www.uab.edu/hcgs). The percentage of
CpG site methylation was then calculated from the elec-
tropherogram by determining the ratio between peak val-
ues of guanine (G) and adenine (A) (G/[G + A]) using
Chromas software (Technelysium Pty Ltd., South Brisbane,
Australia). Methylation percentage for each CpG site
within the DNA amplicon was quantified by measuring
the ratio between peak height values of cytosine (C) and
thymine (T), yielding the basic equation for the methyla-
tion percentage to be (C/[C + T] 9 100) when the for-
ward primer is used for DNA sequencing. If the reverse
primer was used, the guanine (G) and adenine (A) peak
heights were used instead, yielding the equation (G/
[G + A] 9 100). Sequencing was performed using the
reverse primer because it resulted in a cleaner chromato-
gram and more consistent analysis of DNA methylation as
described previously.21–23
Western blotting
To quantify BDNF levels, protein extracts (10 lg) were
separated on 4–12% Nupage BisTris gels (Invitrogen,
Carlsbad, CA). The proteins were transferred onto a Poly-
vinylidene fluoride membrane using a semidry transblot-
ter (Bio-Rad). Blots were then probed with a BDNF
antibody (1:1000, Cat. No. sc-546, Santa Cruz Biotechnol-
ogy Inc., Dallas, Texas, USA). Secondary goat anti-rabbit
800CW antibody was used for protein detection (Licor
Odyssey System, LiCor, Lincoln, NE). Quantifications
were normalized to actin (1:1000, Cat. No. ab1801, Ab-
cam, Cambridge, UK) and valosin-containing protein
(1:5000, #ab11433, Abcam).
Amino acid array
Hippocampal tissue was isolated, flash frozen in 2-meth-
ylbutane, and amino acid levels measured using a high-
performance liquid chromatography (HPLC) system with
autosamplers and a 474 scanning fluorescence detector
(Vanderbilt Brain Institute Neurochemistry core at Van-
derbilt University, http://braininstitute.vanderbilt.edu).
EEG recordings
Two weeks post-SE, animals were anesthetized and main-
tained with 2.5% isofluorane. A dental drill was used to
drill six holes through the skull, bilaterally, ~2–3 mm pos-
terior and lateral to Bregma, ~4 mm posterior to Bregma
and 5 mm lateral to midline, and approximately 6 mm
posterior to Bregma and 3–4 mm lateral to midline. Three
2.4-mm stainless steel screws (Plastics One, Inc., Roanoke,
Virginia, USA) were screwed halfway into the two holes
closest to Bregma and in one hole farthest from Bregma.
Then, an EEG electrode (Plastics One, Inc.) with two lead
wires and a ground wire, cut to a length that would touch
but not penetrate the dural surface (~1.7 mm), were
inserted into the remaining three drill holes, with the
ground wire positioned in one of the holes farthest from
Bregma. The lead wires were placed bilaterally on the cor-
tical surface of the parietal hemispheres in the cortical
region over the underlying hippocampi. This two-elec-
trode system does not allow us to identify the anatomical
origin of epileptic activity. Once the electrode was posi-
tioned, dental acrylic (Darby Dental Supply, Memphis,
TN) was applied to form a stable cap on the skull. When
the acrylic had dried, the scalp was closed with skin glue
(3M Vetbond 3M, Saint Paul, Minnesota, USA). After the
animals were sacrificed, electrodes were confirmed to be
on the surface of the brain. Macroscopically, there
appeared to be no damage to the underlying brain tissue.
One week after electrode placement surgery, rats were
individually housed in specially constructed EEG monitor-
ing cages. EEG data were acquired using Biopac Systems
amplifiers (Biopac EEG100C) and AcqKnowlege 4.2 EEG
Acquisition and Reader Software (Biopac Systems, Inc.,
Goleta, CA). EEG data were stored and analyzed in digital
format. Cages were also equipped with IR Digital Color
CCD cameras (Digimerge Technologies, Markham,
Ontario, Canada) that recorded each animal concurrently
with EEG monitoring; recordings were acquired for review
using security system hardware and software (L20WD800
Series, Lorex Technology, Inc., Linthicum, MD). All col-
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lected data were manually analyzed for abnormalities by
an experienced observer blinded to genotype. All EEG
recordings were scored for the presence of isolated spikes,
repetitive spiking, and seizures while the animals were
awake. Spikes were defined as having a duration of
<200 msec with 59 baseline amplitude, whereas repetitive
spiking activity was defined as ≥3 spikes lasting ≤5 sec.
Seizures were defined as high-frequency and high-ampli-
tude repetitive spiking, or low-frequency, high-amplitude
spike-wave patterns ≥10 sec. The corresponding video of
the animal was analyzed for associated behavior during
these abnormal events. EEG rhythm power analysis was
performed offline in the MATLAB environment. We
obtained the absolute power, and the mean power of brain
alpha (8–13 Hz) and theta (4–8 Hz) frequency bands
every 30 sec from all implanted electrodes (AcqKnowlege
Software BIOPAC, Goleta, California, USA). The absolute
power of a band is the integral of all of the power values
within its frequency range. To calculate the absolute power
and mean power, we used 5 9 30 sec periods for each rat,
15 sec before and 15 sec after the interictal discharge.
Behavioral tests
Animals were handled for three consecutive days prior and
transported 2 h before behavioral experiments in the open
field, contextual fear conditioning, and object location.
Open field
The testing room was dimly lit, and the open-field cham-
ber had a white floor and white walls. The animals were
placed into the chamber for 20 min and allowed to move
freely around the apparatus. Total movement time and
time spent in the center of the open area was calculated
for each animal. Animals were considered to be in the
open area if they were 10 cm away from the walls.
Contextual fear conditioning
The animals were placed in a chamber, allowed to explore
for 2 min, and subjected to a 1-sec, 0.5 mA subthreshold
footshock. This 2 min, 1 sec pairing was repeated three
times over the course of 6 min, ending with a 1-min
exploratory period. Vehicle naive animals were left
untouched in their home cages. For behavioral testing, ani-
mals were placed back in the same chamber 24 h later, and
freezing behavior was monitored for a period of 5 min.
Object location
The animals were placed in an open-field chamber for
five consecutive days. Days 1–3 consisted of habituation
to the chamber for 5 min. On the training day (day 4),
two identical objects (100 mL Pyrex bottles) were placed
10 cm from the corners of the chamber. The rats were
allowed to explore the objects for 15 min. Testing day
(day 5) was 24 h after the training trial. For testing, one
of the objects was placed in the middle of the box, and
the other object was placed in the same location as during
the training trial. Animals were tested for 5 min. Time
spent exploring the objects was recorded and expressed
by a discrimination index (DI = [tnovel  tfamiliar]/
[tnovel + tfamiliar] 9 100%). Time spent with the objects
was calculated and the discrimination indices between
treatment groups were compared.
Statistical analysis
Relative mRNA fold changes for all genes and brain
regions were analyzed using the comparative Ct method.
Due to a lack of homogeneity between groups (Levene
test), mRNA and protein expression data were first trans-
formed using a log10 base transformation. Log10 trans-
formation of mRNA and protein data resulted in a
nonsignificant Levene test. Transformed data were then
analyzed using either a Student’s t-test or one-way analy-
sis of variance (ANOVA), with a Dunnett or Tukey post
hoc test, where appropriate. DNA methylation and behav-
ioral data were analyzed using either a Student’s t-test or
one-way ANOVA with a Tukey post hoc test. IBM SPSS
Statistics, Armonk, New York, USA was used for all sta-
tistical analysis. Significance was set at P ≤ 0.05 for all
analyses. Figures were made in GraphPad Prism Graph-
Pad Software, Inc., La Jolla, California, USA.
Results
Bdnf mRNA and DNA methylation levels are
altered in the epileptic hippocampus during
memory consolidation
To confirm memory deficits in the kainate rodent model
of TLE, epileptic rats (3 weeks post-SE) were trained in
two hippocampus-dependent memory tasks: (1) CFC or
(2) OL (Fig. 1a).24–27 As expected, we found that epileptic
rats displayed markedly reduced freezing behavior in the
CFC memory task (Fig. 1b), suggesting that hippocam-
pus-dependent memory formation was compromised in
our TLE animal model. This finding was further
supported by a lack of memory retention in the OL mem-
ory task (Fig. 1c).
BDNF activity is crucial for proper memory formation
and is significantly increased with epilepsy in both rodent
models and in humans.15,16,18,28 Furthermore, Bdnf tran-
scriptional activation in area CA1 of the hippocampus is
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necessary for proper memory formation and CA1 is also
a region affected with chronic seizures in TLE.29–32 There-
fore, we assessed Bdnf mRNA levels in area CA1 of
epileptic animals during memory consolidation. At 2 h
after CFC, Bdnf mRNA levels were significantly increased
in area CA1 of the untrained epileptic group and the
CFC-trained non-epileptic group compared to non-epi-
leptic untrained group (Fig. 1d). Interestingly, Bdnf
mRNA levels in area CA1 of epileptic CFC-trained group
was significantly greater than levels observed in both the
epileptic untrained group and the CFC-trained non-epi-
leptic group (Fig. 1d), suggesting that Bdnf is further ele-
vated with epilepsy during memory consolidation.
We next assessed Bdnf DNA methylation levels in area
CA1 of the epileptic hippocampus during memory
consolidation. DNA methylation levels at Bdnf promoter 4
were assessed due to the fact that exon IV is the primary
Bdnf exon responsible for activity-dependent Bdnf mRNA
expression.17,33 In Figure 1e, a schematic of the 12 CpG
dinucleotide sites we analyzed by bisulfite sequencing are
shown that encompass part of promoter 4 and the noncod-
ing exon IV region of the Bdnf gene. At 2 h, non-epileptic
Figure 1. Altered brain-derived neurotrophic factor (Bdnf) gene expression and DNA methylation levels in the epileptic hippocampus are
associated with memory deficits. (a) Diagram of experimental setup. (b, c) Epileptic animals displayed hippocampus-dependent memory deficits on
test day at 24 h posttraining in the contextual fear conditioning (CFC) and the object location (OL) memory paradigms (CFC: t(17) = 3.41,
P < 0.01, n = 10–11; OL: t(9) = 3.37, P < 0.01, n = 5–6, t-test, *significance relative to non-epileptic group). (d) Bdnf mRNA levels were
significantly increased in the hippocampus of the non-epileptic, epileptic untrained, and epileptic CFC animals following CFC training compared to
non-epileptic untrained controls. Bdnf mRNA levels were significantly increased in the hippocampus of the epileptic CFC animals compared to all
other groups (F3,18 = 67.58, P < 0.001, n = 5–6, one-way analysis of variance [ANOVA] with post hoc test, *significance relative to non-epileptic
group; #significance between experimental groups). (e) Bisulfite sequencing analysis of 12 CpG sites within promoter 4 and the noncoding exon
IV of the Bdnf gene revealed a significant decrease in DNA methylation levels in the non-epileptic CFC-trained, epileptic untrained, and epileptic
CFC-trained animals compared to the non-epileptic untrained controls. The epileptic CFC group had significantly decreased DNA methylation
compared to all other groups (F3,15 = 11.64, P < 0.001, n = 4–5, one-way ANOVA with post hoc test, *significance relative to non-epileptic
group; #significance between experimental groups). Error bars are SEM.
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CFC-trained and epileptic untrained groups displayed
reduced Bdnf DNA methylation levels, which were inversely
correlated with Bdnf mRNA levels in area CA1 of the hip-
pocampus compared to non-epileptic untrained controls
(Fig. 1e). Bdnf DNA methylation levels were significantly
reduced in area CA1 of epileptic CFC-trained animals com-
pared to all groups assessed, suggesting that Bdnf DNA
methylation was abnormally regulated during memory con-
solidation with epilepsy (Fig. 1e). Together, these data indi-
cate that DNA methylation mechanisms may contribute to
aberrant activity-dependent Bdnf gene transcription in the
epileptic hippocampus during memory consolidation.
Effect of methyl supplementation with
methionine on Bdnf DNA methylation and
mRNA levels in the epileptic hippocampus
during memory consolidation
Methionine (Met) administration has been shown to
increase DNA methylation, and significantly affect neuro-
nal function and behavior.34–38 Therefore, we treated epi-
leptic rats with Met and determined whether manipulating
DNA methylation could affect Bdnf DNA methylation and
mRNA levels in the epileptic brain (Fig. 2a). First, we
determined whether i.p. injection of Met (100 mg/kg) was
sufficient to elevate Met levels in the rat hippocampus, as
this dose has previously been reported to significantly ele-
vate Met levels in the rat brain at 1.5 h after Met i.p.
administration.20 An amino acid array analysis revealed
that Met i.p. injection resulted in a sevenfold increase in
hippocampal Met levels compared to nonepileptic and
non–Met-treated epileptic animals (Table 1). Met treat-
ment significantly decreased Bdnf mRNA levels in the epi-
leptic hippocampus and had no effect on Bdnf mRNA
levels of the nonepileptic animals (Fig. 2b). Additionally,
Met administration significantly increased Bdnf DNA
methylation in the epileptic hippocampus (Fig. 2c). These
results suggest that methyl supplementation with Met can
decrease Bdnf gene transcription and increase Bdnf DNA
methylation in the epileptic hippocampus.
Next, we assessed the effects of methyl supplementation
with Met on Bdnf DNA methylation and mRNA levels
during memory consolidation (Fig. 2d). We found that
Met administration significantly increased DNA methyla-
tion levels in area CA1 of epileptic CFC-trained animals,
and elevated Bdnf DNA methylation to levels similar to
the nonepileptic CFC-trained group (Fig. 2e). Interest-
ingly, Met had its strongest effect at CpG sites 5, 8, and
12 of the Bdnf CpG sties assayed, suggesting that these
sites may be of particular importance in Bdnf transcrip-
tion. In fact, CpG site 8 encompasses a transcription fac-
tor-binding site for specificity protein 1 (Sp1) that might
have been disrupted due to physical hindrance by the
methyl functional group found within the Sp1 DNA con-
sensus sequence (Fig. 2f). In response to Met treatment,
Bdnf DNA methylation changes correlated with decreased
Bdnf mRNA levels in area CA1 of epileptic animals dur-
ing memory consolidation (Fig. 2g). These results suggest
that in the epileptic hippocampus, methyl supplementa-
tion via Met affects activity-dependent Bdnf transcription
during memory consolidation.
Methyl supplementation via methionine
reduces interictal spike activity, improves
theta rhythm power, and reverses
hippocampus-dependent memory
impairments with epilepsy
Due to the robust effects of methyl supplementation with
Met on Bdnf mRNA levels in the epileptic hippocampus
during memory consolidation, we next investigated
whether Met administration could alter hippocampus-
dependent memory formation in epileptic animals
(Fig. 3a). Met treatment did not significantly alter freez-
ing behavior in nonepileptic CFC-trained animals; how-
ever, Met administration reversed memory impairments
in epileptic CFC-trained animals (Fig. 3b). We confirmed
the effect of Met administration on hippocampus-depen-
dent memory using the OL memory task and found that
Met reversed memory deficits observed in epileptic ani-
mals during OL memory consolidation (Fig. 3c). Impor-
tantly, methyl supplementation via Met had no adverse
effects on freezing behavior during CFC training (Fig. 3d)
or on anxiety and mobility activity using the open-field
test (Fig. 3e), suggesting that the rescue of epilepsy-
related memory deficits via Met occurred independent of
changes in locomotor activity, exploration, or anxiety.
Recent studies have demonstrated that interictal spiking
may contribute to epilepsy-related memory deficits.39,40
Therefore, we investigated whether methyl supplementa-
tion via Met could affect interictal spike activity using con-
tinuous EEG-video monitoring on epileptic animals
(Fig. 4a). In Figure 4b, a representative trace of interictal
spikes are shown. In the first 24 h following Met treatment,
interictal spike rates were significantly reduced, suggesting
that methyl supplementation with Met has a strong, yet
short-acting influence on interictal spiking, as EEG activity
showed a trend toward returning back to baseline 24 h
later (Fig. 4c). No difference was found in number of sei-
zures per day or seizure duration due to Met treatment in
the epileptic animals (Fig. 4d and e), suggesting that Met
treatment does not directly affect seizure activity.
We next performed an analysis of the power spectrum
surrounding spiking events, focusing in particular on the
theta band, since this has been shown to be important in
a number of cognitive processes and may contribute to
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epilepsy-related memory deficits.41–43 Additionally, methyl
supplementation has been show to improve theta rhythm
power in humans.44,45 The power spectrum revealed that
there was a broad increase in rhythm power at the lower
frequencies, between 2 and 18 Hz post-Met treatment
(Fig. 5a), which encompasses the theta and alpha
rhythms. The mean power of theta rhythm was signifi-
cantly increased in epileptic animals post-Met treatment
(Fig. 5d). In addition, on the second day post-Met treat-
ment, the mean power of alpha was significantly increased
in the epileptic animals (Fig. 5c). It is therefore possible
that the effect of methionine on interictal activity and
theta rhythm power contributed to the restoration of
memory deficits in our rodent model of TLE.
DNMT inhibition prevented the effects of
methionine
Next, we considered whether DNMT inhibition would
block outcomes of methyl supplementation with Met
Figure 2. Methyl supplementation with methionine (Met) alters hippocampal brain-derived neurotrophic factor (Bdnf) gene DNA methylation and
mRNA levels in epileptic animals. (a) Diagram of experimental setup. (b) Methyl supplementation with Met significantly reduced Bdnf mRNA levels
in the hippocampus of the epileptic animals (F3,24 = 9.99, P < 0.001, n = 6–8, one-way analysis of variance [ANOVA] with post hoc test,
*significance relative to non-epileptic group; #significance between experimental groups). (c) Methyl supplementation with Met significantly
increased Bdnf DNA methylation in the epileptic hippocampus (F3,12 = 4.26, P < 0.05, n = 4, one-way ANOVA with post hoc test, *significance
relative to nonepileptic group; #significance between experimental groups). (d) Experimental design setup. (e) Decreased Bdnf DNA methylation in
the epileptic contextual fear conditioning (CFC) group was rescued by Met supplementation (F3,22 = 15.06, P < 0.001, n = 5–9, one-way ANOVA
with post hoc test, *significance relative to non-epileptic; #significance relative to non-epileptic CFC; §significance relative to epileptic CFC). (f) A
schematic of transcription factor (TF)-binding regulatory elements within the rat Bdnf exon IV transcription start site (TSS). The cAMP response
element-binding (CREB) TF is known to bind to the depicted sequence within the Bdnf gene while the depicted Sp1-binding site is considered to
be a putative site. (g) Methyl supplementation with Met significantly reduced Bdnf mRNA levels in the hippocampus of CFC-trained epileptic
animals (F3,19 = 48.69, P < 0.001, n = 5–6, one-way ANOVA with post hoc test, *significance relative to non-epileptic group;
#significance
between experimental groups). Error bars are SEM.
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including Bdnf DNA methylation and mRNA expression,
and reversal of memory deficits (Fig. 6a). 5-Aza-20-deoxy-
cytidine (5-AZA) was chosen for DNMT inhibition
because it can be i.p. injected and at the administered
dose, has been previously reported to alter behavior,
DNA methylation, and BDNF expression in the hippo-
campus.46 DNMT inhibition with 5-AZA blocked the
effect of methyl supplementation via Met on Bdnf DNA
methylation, specifically at CpG sites 1, 2, 3, 4, 5, 8, and
12 within the Bdnf gene (Fig. 6b). Interestingly, CpG site
1 encompasses a binding site for the transcription factor
cAMP response element-binding (CREB) protein,47 while
CpG site 8 encompasses a putative Sp1 transcription fac-
tor-binding site as mentioned earlier, suggesting that
aberrant methylation at these sites could affect Bdnf
expression by disrupting transcription factor binding
(Fig. 2f). Additionally, DNMT blockade partially attenu-
ated the decrease in Bdnf mRNA (Fig. 6c) and protein
expression observed with methyl supplementation
(Fig. 6d). These findings strongly support that the effect
of methyl supplementation on Bdnf gene and protein
expression is partly due to DNA methylation mechanisms
in the epileptic hippocampus during memory consolida-
tion. Importantly, DNMT inhibition also prevented the
memory rescue observed with Met treatment of epileptic
CFC-trained animals (Fig. 6e), suggesting that methyl
supplementation reversed memory impairments in a
rodent model of TLE via DNA methylation mechanisms.
Discussion
TLE is a debilitating disorder with many associated com-
orbidities including declarative memory loss. While phar-
macological treatments may reduce the incidence of
seizures, memory deficits often go untreated and the
underlying mechanisms remain poorly understood. Persis-
tent, aberrant changes in gene expression that occur in
the epileptic brain are believed to have proepileptic impli-
cations.14 Paradoxically, memory consolidation requires
de novo transcription of numerous genes in the hippo-
campus that have been implicated in epilepsy, suggesting
that gene expression changes in the epileptic hippocam-
pus can have enduring effects on long-term memory for-
mation. For example, Bdnf, a gene widely implicated in
the process of memory formation,18 is known to be
abnormally increased in the epileptic hippocampus12,48,49
and partial knockdown or overexpression of brain Bdnf
interferes with memory formation,15,16 further demon-
strating that alterations of memory-permissive genes like
Bdnf expression, results in memory deficits. Therefore,
abnormal increases in hippocampal Bdnf gene expression
with epilepsy may contribute to memory impairments
associated with the disorder.
For the present studies, we chose to focus on one can-
didate gene, Bdnf, because of its well-established role in
memory formation and because BDNF expression and
function is significantly altered in TLE.12,18,48 However, it
is noteworthy to mention that many genes are impacted
by DNA methylation mechanisms in the hippocampus
during memory formation.2,3,50 Thus, our present studies
do not exclude the possibility that DNA methylation
changes at other genes may have also been impacted by
Met supplementation.35,37
Currently, the literature is controversial as to the exact
role that BDNF alone would play in effectively restoring
memory formation in disease states such as in epilepsy.
Previous studies support that activity-dependent increases
in BDNF levels are necessary for normal memory forma-
tion. However, epilepsy results in exacerbated levels of
BDNF, which may contribute to memory deficits with epi-
lepsy.16,51 Furthermore, other studies have made impor-
tant links between increased BDNF and posttraumatic
Table 1. Amino acid levels in the epileptic hippocampus following
methionine treatment.
Amino acids
(pmol/lg protein) Non-epileptic Epileptic Epileptic + Met
Methionine 1.4 1.3 8.3***###
Aspartic 59.5 52.6 44.0
Serine 36.3 29.2 27.6*
Glutamic acid 261.8 214.3 187.5*
Glycine 22.0 12.9*** 10.6***
Histidine 106.4 92.6 90.2
Taurine 219.8 194.6 194.5
Arginine 3.1 3.9 6.3*
Threonine 17.2 15.6 15.3
Alanine 21.0 17.8 16.8
Proline 15.2 13.2 11.3
GABA 41.2 34.5 36.5
Cystine 2.3 2.3 2.5
Tyrosine 2.9 2.2* 2.0*
Valine 1.8 1.7 1.6
Lysine 4.8 5.1 5.7
Isoleucine 129.5 118.2 125.0
Phenylalanine 1.6 1.4 1.4
Leucine 2.5 2.4 2.4
Epileptic animals show significant deficits in glycine and tyrosine levels
compared to vehicle (saline)-treated non-epileptic controls. Met-trea-
ted epileptic animals showed a sevenfold increase in hippocampal
Met levels compared to non-epileptic and epileptic groups. Met-trea-
ted epileptic animals had significantly lower serine, glutamic acid, gly-
cine, and tyrosine levels compared to the non-epileptic group.
Arginine levels were significantly elevated in the hippocampus of epi-
leptic Met-treated animals compared to the non-epileptic group.
(*P < 0.05, ***P < 0.001, ###P < 0.001; n = 4, one-way ANOVA with
post hoc test. *Significance relative to non-epileptic animals; #signifi-
cance relative to epileptic animals). ANOVA, analysis of variance;
GABA, c-aminobutyric acid.
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stress disorder,52 which is associated with memory deficits.
Additionally, infusion of BDNF in the hippocampus
increases seizure activity.12 Thus, an interesting idea is that
overexpression of BDNF may contribute to memory defi-
cits by increasing cortical activity and seizure susceptibil-
ity.51 It is reasonable to speculate that decreasing BDNF
expression in an epileptic brain might decrease hyperexcit-
ability to allow for proper memory formation with epi-
lepsy. Our results suggest that aberrant regulation of the
Bdnf gene via DNA methylation mechanisms is strongly
correlated with epilepsy-related memory deficits, however,
further work is needed to elucidate the direct role of Bdnf
DNA methylation alone on cognitive deficits in epilepsy.
Recent work has established that DNA methylation is
altered in epilepsy and that these molecular changes
contribute to persistent gene regulation in the hippocam-
pus.7,9–11 However, whether DNA methylation in the
epileptic hippocampus is a pro- or antiepileptic mechanism
Figure 3. Methyl supplementation reverses hippocampal memory deficits associated with epilepsy. (a) Diagram of experimental setup. (b) Methyl
supplementation rescued memory impairments in the epileptic animals in the contextual fear conditioning (CFC) paradigm (F3,36 = 5.95, P < 0.01,
n = 10–11, one-way analysis of variance [ANOVA] with post hoc test, *significance relative to non-epileptic group). (c) Methyl supplementation
rescued memory deficits in the epileptic animals in the object location (OL) paradigm (F3,19 = 7.06, P < 0.01, n = 5–6, one-way ANOVA with post
hoc test, *significance relative to non-epileptic group). (d) Methyl supplementation had no effect on fear conditioning training (F3,26 = 7.68,
P < 0.01, n = 7–9, one-way ANOVA with post hoc test, *significance relative to non-epileptic group; #significance between experimental groups).
(e) Methyl supplementation with Met did not significantly alter movement time in the open-field paradigm. Epileptic animals showed greater
mobility compared to non-epileptic rats (F3,24 = 5.53, P < 0.01, n = 6–8, one-way ANOVA with post hoc test, *significance relative to non-
epileptic group; #significance between experimental groups). (f) Methyl supplementation with Met did not alter the time spent in the open arena
during the open-field paradigm (F3,24 = 1.46, P > 0.05, n = 6–8, one-way ANOVA with post hoc test). Error bars are SEM.
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remains undetermined. For example, prior studies suggest
that in the epileptic hippocampus, global increases in DNA
methylation may act to dampen hyperexcitability through
downregulation of gene expression, as DNMT inhibition in
area CA1 with zebularine resulted in a decreased latency to
seizures when administered prior to SE and increased cell
excitability in epileptic animals.10 Interestingly, another
report suggests that DNMT inhibition using 5-AZA,
administered in an electrical kindling model of epilepsy
decreased seizure severity.11 It is important to note that dif-
ferences in research approach, design, and experimental
epilepsy animal model used may have contributed to the
conclusions drawn from these DNMT inhibitor studies.
Thus, additional studies are warranted to fully elucidate the
role of DNA methylation in epilepsy.
One mechanism for elevating DNA methylation levels
in the brain is through methyl supplementation with Met
or its derivative S-adenosyl methionine (SAM), the uni-
versal methyl donor in the brain. Met or SAM adminis-
tration has been shown to alter global and gene-specific
DNA methylation levels in the brain and with experience-
driven behavioral change.11,35–38 Additionally, methyl
supplementation with Met has been shown to reverse
lead-induced memory deficits and to reduce seizures
in a transgenic mouse model.34,53,54 Therefore, global
modification of the methylome with epilepsy compro-
Figure 4. Methyl supplementation decreases interictal spiking. (a) Diagram of experimental setup. (b) Representative trace of interictal spikes
observed in epileptic rats 3 weeks post-KA administration (* represents what was counted as a spike). (c) Methyl supplementation significantly
reduced interictal spike number in the first 24 h postinjection. Interictal spiking rate showed a trend toward returning back to baseline at 24–
48 h post-Met supplementation (F2,6 = 4.06, P < 0.05, n = 7, one-way analysis of variance [ANOVA] with post hoc test, *significance relative to
pre-Met). (d) Methyl supplementation did not have a significant effect on number of seizures per day (F2,18 = 0.82, P > 0.05, n = 7, one-way
ANOVA with post hoc test). (e) Methyl supplementation did no significantly affect duration of seizures (F2,23 = 0.91, P > 0.05, n = 3–16, one-way
ANOVA with post hoc test, ns = not significant). Error bars are SEM.
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mises transcriptional regulation of memory-permissive
genes in the hippocampus that is required for proper
memory formation. In consideration that DNA methyla-
tion at the Bdnf gene is significantly decreased in the epi-
leptic hippocampus,10 we studied the effect of promoting
methylation events such as DNA methylation at this gene
promoter and on TLE-associated hippocampus-dependent
memory deficits. We hypothesized that increasing DNA
methylation mechanisms via methyl supplementation with
Met might serve as an ideal therapeutic approach for
restoring Bdnf gene regulation and proper hippocampus-
dependent memory formation in a rodent TLE model.
In the present study, we found that Met administration
significantly elevated Bdnf DNA methylation levels in the
hippocampus of untrained epileptic animals and returned
hippocampal Bdnf mRNA levels back to levels comparable
to untrained non-epileptic animals. In response to a
learning experience methyl supplementation with Met sig-
nificantly increased hippocampal Bdnf DNA methylation
and reduced chronic overexpression of Bdnf mRNA levels
observed in the hippocampus of epileptic animals during
memory consolidation. These findings strongly support
that methyl supplementation with Met restored hippo-
campus-dependent memory formation via a DNA methyl-
ation-regulatory mechanism. These findings are further
supported by previous studies demonstrating that Met
treatment can restore proper DNA methylation levels at
other genes such as the reelin and glucocorticoid receptor
(GR) promoters while altering reelin and GR transcript
expression in the hippocampus of rodent models of
schizophrenia and maternal care, respectively.37,55 These
prior findings and our present studies suggest that pro-
moting DNA methylation may serve to restore proper
gene expression, not only with epilepsy disorders but also
with other neurological disorders.
Interestingly, we found that Met treatment did not sig-
nificantly alter global DNA methylation levels in non-epi-
leptic animals. The following factors could have
contributed to these results. First, in the present study we
administered only a single, acute injection of Met,
Figure 5. Methyl supplementation increased theta and alpha rhythm power. (a) Power spectrum density surrounding interictal spikes. (b) Methyl
supplementation significantly increased theta rhythm power (F2,5 = 12.30, P < 0.01, n = 6, one-way analysis of variance [ANOVA] with post hoc
test, *significance relative to pre-Met). (c) Methyl supplementation significantly increased alpha rhythm power on day 2 post-Met treatment
(F2,5 = 5.90, P < 0.05, n = 6, one-way ANOVA with post hoc test, *significance relative to pre-Met). Error bars are SEM.
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whereas prior studies administered Met, chronically.35–38
Therefore, future studies should focus on further evaluat-
ing the effect of chronic or intermittent treatment of Met
in experimental TLE animals compared to controls.
Second, because fluctuations in DNA methylation levels
are intimately linked to the degree of neuronal function
Figure 6. DNA methyltransferases (DNMT) inhibition prevents the effect of methyl supplementation on hippocampal brain-derived neurotrophic
factor (Bdnf) DNA methylation, Bdnf expression and memory formation. (a) Diagram of experimental setup. (b) The increase in Bdnf DNA
methylation due to methyl supplementation is blocked by DNMT inhibition (F4,18 = 6.93, P < 0.01, n = 3–6, one-way analysis of variance
[ANOVA] with post hoc test, *significance relative to non-epileptic group; # significance relative to epileptic group; §significance relative to
epileptic + Met group). (c) DNMT inhibition attenuated the effect of methyl supplementation with Met on Bdnf mRNA levels in the epileptic
hippocampus (F4,24 = 11.96, P < 0.001, n = 5–8, one-way ANOVA with post hoc test, *significance relative to non-epileptic group;
#significance
between experimental groups). (d) BDNF protein expression was significantly reduced in Met-treated epileptic animals compared to nontreated
epileptic animals. DNMT inhibition attenuated the decrease in BDNF protein expression due to methyl supplementation with Met. Duplicates of
each sample were run and normalized to valosin-containing protein (VCP) and beta-actin 4 as within-lane loading controls. Representative blots
of samples from each treatment group are shown (F3,14 = 3.84, P < 0.05, n = 5–6, one-way ANOVA with post hoc test, *significance relative
to epileptic group). (e) DNMT inhibition blocked Met-induced memory enhancement (F4,31 = 7.81, P < 0.001, n = 7–8, one-way ANOVA with
post hoc test, *significance relative to non-epileptic group; #significance between experimental groups). Error bars are SEM. (f) Potential
mechanism of the effect of methionine treatment on memory restoration in epileptic animals. Shaded words represent the molecular
mechanisms demonstrated in the present study. Unshaded words and dotted lines are potential pathways that could also be involved in the
memory restoration process with methionine. Thus, methionine can be rapidly converted to S-adenosyl methionine (SAM), the universal methyl
donor in the brain. SAM donates a CH3 group that leads to increased DNA methylation and gene transcription changes in the epileptic
hippocampus. Once SAM donates a methyl group, it is converted to S-adenosyl-L-homocysteine (SAH), which leads to the production of
adenosine. Adenosine production can lead to decreases in cell excitability that could subsequently decrease interictal spike activity in the
epileptic hippocampus. Arginine is also a downstream by product of SAH hydrolysis that can lead to changes in nitric oxide production and can
affect cell excitability.
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and seizure activity results from intense, synchronized,
neuronal network hyperactivity,5 it is plausible to con-
sider that there may be changes in DNA methylation lev-
els at other genes in the epileptic hippocampus in
response to methyl supplementation. Finally, increased
DNMT expression is observed with epilepsy, suggesting
that a greater rate of de novo DNA methylation might
occur in an epileptic brain and thus a greater demand for
methyl turnover than in a non-epileptic brain.56 Nonethe-
less, we found that methyl supplementation with Met
could reverse memory deficits associated with epilepsy
using two hippocampus-dependent rodent memory para-
digms. These findings are in strong agreement with previ-
ous studies demonstrating that methyl supplementation
can alter behavior and reverse memory impairments.34–
37,53,57
Furthermore, it has been hypothesized that interictal
spike activity is a major contributor to epilepsy-related
memory deficits.39,40,58 Where previous findings demon-
strated that daily methyl supplementation reduced sei-
zures in a line of transgenic mice,54 we found that one
acute administration of methyl supplementation was not
sufficient to reduce number of seizures or seizure fre-
quency. However, we did observe that Met treatment
decreased interictal spike activity in epileptic rats. More-
over, theta rhythm power has been linked to memory for-
mation and long-term potentiation59–61 and degradation
of theta frequency oscillations are believed to contribute
to memory deficits in epilepsy.41–43 Based on these previ-
ous studies and a report that demonstrated that methyl
supplementation increases theta rhythm power in
humans,45 we sought to determine whether oscillatory
power was altered in epileptic animals following supple-
mentation of Met. We found that methyl supplementa-
tion with Met resulted in a marked increase in theta
rhythm power. There was also an increase in alpha power
on the second day following Met treatment, but this effect
was only present after the behavioral testing and is there-
fore unlikely to have impacted our behavior results. How-
ever, due to alpha’s rhythms presumed role in cognitive
inhibition,62 increased alpha power may have an effect on
seizure activity but is beyond the scope of this study. We,
therefore, hypothesize that another benefit of methyl sup-
plementation is a reduction in interictal spike activity and
an increase in theta rhythm power that may help promote
proper memory consolidation in epileptic animals. The
pathogenetic mechanism of this intriguing finding
remains to be elucidated; however, we speculate that
decreasing BDNF alone may result in decreased cortical
network activity. Importantly, several studies have dem-
onstrated that increasing BDNF results in seizure activity
while partial knockdown of Bdnf is neuroprotective
against seizure activity.12,49,51,63
The effect of BDNF on interictal spiking activity in epi-
lepsy is well documented. For example, prior studies dem-
onstrate that an antagonist (K252a) of BDNF-TrkB
signaling effectively reduced the probability of multiple
population spike peaks, delayed the latency of spontaneous
spikes, and reduced the burst frequency induced by subcu-
taneous injection of Pentylenetetrazole, a widely used con-
vulsant in studies of epilepsy.64 Additionally, numerous
rodent studies have also demonstrated that blockade of
TrkB receptors leads to increased neuroprotection from
electrical and chemoconvulsant-induced seizure activity,
and in TrkB knockout mice prevents epileptogenesis.49,65
In agreement with these prior studies, we demonstrate that
BDNF is abnormally regulated in the epileptic hippocam-
pus in association with increased spiking activity. Never-
theless, while our findings in the present study provide
basic insights into the epigenetic regulation of memory-
permissive genes such as Bdnf during memory formation
with epilepsy, future electrophysiological studies of epi-
lepsy are necessary to further explore how BDNF-TrkB sig-
naling couples with DNA methylation mechanisms to
influence spiking activity and theta rhythms in epilepsy.
In additional studies, we found that these effects were
indeed DNA methylation-dependent, as DNMT inhibition
with 5-AZA attenuated the Met-enhancing effect on Bdnf
DNA methylation levels and the normalization of Bdnf
gene transcription in the epileptic hippocampus during
memory consolidation. Furthermore, DNMT inhibition
prevented the memory rescue effect of methyl supplemen-
tation with Met. Collectively, these data support the
hypothesis that epilepsy induces memory deficits via a
DNA methylation-regulatory mechanism, which can be
overcome by methyl supplementation with Met. However,
it is possible that methyl supplementation with Met could
have initiated other metabolic pathways involved in the
rescue of the epilepsy-related memory deficits (Fig. 6f).
Indeed, we observed a marked decrease in glycine levels
in the hippocampus of epileptic animals (Table 1 and
Fig. 6f). Glycine is converted to sarcosine, which may
account for a large amount of Met consumption.66 There-
fore, deficiencies in hippocampal glycine may contribute
to the observed increases in baseline DNA methylation
levels in the epileptic hippocampus compared to a non-
epileptic hippocampus following Met administration.
In summary, we conclude that methyl supplementation
with Met has profound effects on hippocampal Bdnf DNA
methylation, gene transcription, and cognition in a rodent
model of TLE. The present findings provide novel insight
into a powerful transcriptional regulator of gene expression
that may contribute to memory impairments associated
with epilepsy disorders. Specifically, we expand on the role
of Bdnf transcriptional regulation in hippocampus-depen-
dent memory formation and how abnormal activity of this
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gene may affect memory formation with TLE. In silico
analysis of the Bdnf gene (Fig. 2f), along with previous
studies17,67 reveal several transcription factor-binding sites
at Bdnf promoter 4 that underscores the importance of
altering DNA methylation-mediated gene transcription in
the epileptic hippocampus. Importantly, we provide a
novel therapeutic approach for treatment of memory
impairments that often accompany epilepsies and other
neurodegenerative disorders as well. Our data show that a
single, acute administration of Met has a positive effect on
hippocampus-dependent memory formation by altering
DNA methylation-mediated transcriptional events and
reducing cellular excitability in a rodent model of TLE.
We caution, however, that it has been reported that
chronic administration of Met at high doses can lead to
hypermethioninemia, a condition that occurs when there
is a high amount of methionine in the body.68 High doses
of Met have been shown to result in memory deficits in ze-
brafish.69 Therefore, future studies should focus on deter-
mining the long-term effects of Met supplementation in
epilepsy. Additionally, while our results are promising,
here we tested the effect of Met treatment in one experi-
mental rodent model of TLE. Thus, further work is neces-
sary to determine its effectiveness in other models of
epilepsy. Indeed, intriguing questions still remain as to
whether acute or continuous treatment with Met can
impact seizure frequency, other epileptiform activity pat-
terns, progression of epilepsy, or sustain the associated res-
cue of memory deficits with TLE.
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